Chemoinformaics analysis of ARISTOLOCHIC-ACID-II
| Molecular Weight | 488.709 | nRot | 2 |
| Heavy Atom Molecular Weight | 440.325 | nRig | 27 |
| Exact Molecular Weight | 488.35 | nRing | 5 |
| Solubility: LogS | -3.641 | nHRing | 0 |
| Solubility: LogP | 4.285 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 86.1161 |
| nHD | 4 | BPOL | 49.0219 |
| QED | 0.402 |
| Synth | 4.924 |
| Natural Product Likeliness | 3.315 |
| NR-PPAR-gamma | 0.851 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.049 |
| CACO-2 | -5.35 |
| MDCK | 0.000019 |
| BBB | 0.625 |
| PPB | 0.96767 |
| VDSS | 0.673 |
| FU | 0.0487691 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.335 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.908 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.324 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.213 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.156 |
| CL | 2.487 |
| T12 | 0.059 |
| hERG | 0.002 |
| Ames | 0.035 |
| ROA | 0.1 |
| SkinSen | 0.007 |
| Carcinogencity | 0.069 |
| EI | 0.014 |
| Respiratory | 0.913 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.602406 |